Cambridge Capital Group

Cambridge GaN Devices specializes in the design, development, and commercialization of gallium nitride (GaN) power devices aimed at enhancing energy efficiency across various electronic applications. The company produces a range of GaN-based semiconductor products that significantly improve power conversion and minimize energy loss in systems used in sectors such as renewable energy, electric vehicles, and consumer electronics. These transistors are characterized by their speed, reduced power loss, smaller size compared to traditional silicon alternatives, and greater energy storage and conversion capabilities. By collaborating with industry partners, Cambridge GaN Devices promotes innovation and facilitates the adoption of its advanced technology within the power semiconductor market, contributing to the advancement of greener technologies.

Spotta Ltd is a company based in Cambridge, United Kingdom, that specializes in developing smart pest detection systems for the hospitality industry. Founded in 2018, Spotta offers an innovative battery-powered insect monitoring sensor designed to detect bed bug infestations at an early stage. The sensor alerts users when bed bugs are detected and analyzes the findings to ensure notifications are sent only for genuine incidents. This proactive approach allows hotels and lodging providers to prevent bed bugs from entering guest rooms, facilitating easier and more cost-effective treatment options. Spotta's technology aims to enhance guest comfort and safety while minimizing the impact of bed bug infestations on the hospitality sector.

Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.

Qualus is a company focused on providing sustainable solutions for the leather industry, aiming to minimize the environmental impact of leather tanneries. The firm has developed a technology that utilizes small polymer granules known as Sferes, which assist tanneries in conserving water, lowering production costs, and enhancing the quality of leather products. By implementing this technology, Qualus enables its clients to reduce their energy consumption and carbon emissions, contributing to a more eco-friendly leather production process. The company has recently secured £3 million in financing to further advance its sustainable initiatives.

Cambridge GaN Devices specializes in the design, development, and commercialization of gallium nitride (GaN) power devices aimed at enhancing energy efficiency across various electronic applications. The company produces a range of GaN-based semiconductor products that significantly improve power conversion and minimize energy loss in systems used in sectors such as renewable energy, electric vehicles, and consumer electronics. These transistors are characterized by their speed, reduced power loss, smaller size compared to traditional silicon alternatives, and greater energy storage and conversion capabilities. By collaborating with industry partners, Cambridge GaN Devices promotes innovation and facilitates the adoption of its advanced technology within the power semiconductor market, contributing to the advancement of greener technologies.

Porotech is a spin-out from the University of Cambridge that specializes in the development of wide-bandgap gallium nitride (GaN) semiconductors. Co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver, the company focuses on applying advanced material technologies to maximize the potential of GaN. This innovation aims to transform the electronics industry by enhancing the efficiency of light-emitting diodes and other electronic devices, thereby enabling a wide range of applications. Through its cutting-edge approaches, Porotech is positioned to contribute significantly to the advancement of energy-efficient semiconductor solutions.

SupaPass is a versatile platform designed for businesses to create their own websites and mobile applications without requiring technical expertise. Founded in 2011, SupaPass enables clients to launch aesthetically appealing and payment-ready content platforms that cater to a diverse range of sectors, including podcasting, fitness, music, and charities. Its innovative white-label technology allows clients to retain full ownership of their customer data and 100% of sales revenue. By offering an intuitive and cost-effective solution, SupaPass makes it significantly faster and cheaper for content creators to manage their offerings, including podcasts, videos, and streaming channels. The platform features a user-friendly layout reminiscent of popular streaming services, empowering clients to maintain their own branding while effectively engaging with their audiences.

SupaPass is a versatile platform designed for businesses to create their own websites and mobile applications without requiring technical expertise. Founded in 2011, SupaPass enables clients to launch aesthetically appealing and payment-ready content platforms that cater to a diverse range of sectors, including podcasting, fitness, music, and charities. Its innovative white-label technology allows clients to retain full ownership of their customer data and 100% of sales revenue. By offering an intuitive and cost-effective solution, SupaPass makes it significantly faster and cheaper for content creators to manage their offerings, including podcasts, videos, and streaming channels. The platform features a user-friendly layout reminiscent of popular streaming services, empowering clients to maintain their own branding while effectively engaging with their audiences.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, specifically through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging method enables real-time cancer detection during surgical procedures, which can significantly reduce the chances of cancer recurrence and the need for subsequent operations. Lightpoint Medical's tools are designed to enhance the effectiveness of robotic cancer surgeries, providing healthcare professionals with critical insights that improve surgical decision-making and patient outcomes while also aiming to lower healthcare costs.

Sorex Sensors Limited specializes in the design and manufacturing of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for various industrial and consumer applications. Established in 2017 and headquartered in the United Kingdom, the company fabricates its devices on silicon wafers, utilizing a thin film of piezoelectric material. This innovative technology enables the sensors to measure mass by detecting changes in resonant frequency when mass is applied to the surface. Sorex's products are characterized by their ability to measure mass down to the femtogram range, simultaneous mass and temperature measurements with high sensitivity, and low power consumption. The sensors are particularly effective for thin film metrology, particulate monitoring, and gas detection, making them suitable for applications that require precise detection of small masses in compact form factors. Additionally, the functionalization of the sensor surfaces allows for selective detection of specific targets, enhancing their utility in various environments.

Danio Lab is a company dedicated to advancing biomedical research by offering innovative services and tools tailored for the scientific community. It specializes in developing a zebrafish husbandry platform and associated devices that enhance research capabilities. Danio Lab provides comprehensive services, including aquatics room layout and system design, as well as installation services to either upgrade existing aquatics facilities or construct new laboratories for researchers. Through its expertise, the company aims to facilitate more efficient and effective research processes in the field of biomedical science.

SupaPass is a versatile platform designed for businesses to create their own websites and mobile applications without requiring technical expertise. Founded in 2011, SupaPass enables clients to launch aesthetically appealing and payment-ready content platforms that cater to a diverse range of sectors, including podcasting, fitness, music, and charities. Its innovative white-label technology allows clients to retain full ownership of their customer data and 100% of sales revenue. By offering an intuitive and cost-effective solution, SupaPass makes it significantly faster and cheaper for content creators to manage their offerings, including podcasts, videos, and streaming channels. The platform features a user-friendly layout reminiscent of popular streaming services, empowering clients to maintain their own branding while effectively engaging with their audiences.

Featurespace is a leading company specializing in enterprise financial crime prevention, focusing on fraud and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are integrated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries, allowing financial institutions to detect suspicious activities and mitigate fraud in real-time. The ARIC Risk Hub employs advanced anomaly detection techniques to help organizations identify and respond to emerging fraud threats while ensuring legitimate customer transactions are not hindered. With over 30 major global financial institutions utilizing its platform, Featurespace aims to enhance fraud management, improve customer satisfaction, and drive revenue growth for its clients.

DefiniGEN Limited is a biotechnology company based in Cambridge, United Kingdom, specializing in the production of human cell products for the life science and drug discovery sectors. Founded in 2012, the company utilizes its proprietary OptiDIFF stem cell production platform to create high-functionality cell types, including human hepatocytes and pancreatic cells, which are essential for predictive toxicology and drug discovery. DefiniGEN's offerings encompass a range of disease models, such as those for diabetes, hepatitis, and hypercholesterolemia, facilitating research and development in these areas. The company also provides custom services, including gene-editing custom cell line development and contract services for diabetes compound profiling. By leveraging advanced technologies and expertise in induced pluripotent stem cell production, DefiniGEN aims to enhance the efficacy and safety of new treatments, ultimately benefiting pharmaceutical clients in their research efforts.

Spectral Edge Ltd, established in 2011 and headquartered in Cambridge, UK, specializes in image enhancement technologies. The company develops innovative solutions such as Phusion, which improves image and video quality by leveraging information outside the visible spectrum, and Eyeteq, a video personalization technology that enhances TV accessibility for color-blind individuals. Spectral Edge's products cater to consumer electronics manufacturers and service providers, serving applications like computational photography, security, and consumer electronics. As of 2019, the company operates as a subsidiary of Apple Inc.

SupaPass is a versatile platform designed for businesses to create their own websites and mobile applications without requiring technical expertise. Founded in 2011, SupaPass enables clients to launch aesthetically appealing and payment-ready content platforms that cater to a diverse range of sectors, including podcasting, fitness, music, and charities. Its innovative white-label technology allows clients to retain full ownership of their customer data and 100% of sales revenue. By offering an intuitive and cost-effective solution, SupaPass makes it significantly faster and cheaper for content creators to manage their offerings, including podcasts, videos, and streaming channels. The platform features a user-friendly layout reminiscent of popular streaming services, empowering clients to maintain their own branding while effectively engaging with their audiences.

Arquer Diagnostics Ltd. is a diagnostics company specializing in the design, development, and commercialization of non-invasive immunoassay diagnostic tests for bladder and prostate cancer. The company offers an enzyme-linked immunosorbent assay (ELISA) for measuring specific substances in body fluids, including a CE-marked ELISA kit for Mcm5, which is used in hospital pathology laboratories. Additionally, Arquer provides a point-of-care system that includes a robust reader instrument and disposable cartridges, facilitating the use of its tests in urology clinics, hospital laboratories, and general practice surgeries. Founded in 2005 and based in Sunderland, United Kingdom, Arquer Diagnostics aims to enhance cancer diagnosis and monitoring through its innovative technology, which detects a protein linked to the MCM5 gene, improving the accuracy and reliability of test results for patients and clinicians.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, specifically through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging method enables real-time cancer detection during surgical procedures, which can significantly reduce the chances of cancer recurrence and the need for subsequent operations. Lightpoint Medical's tools are designed to enhance the effectiveness of robotic cancer surgeries, providing healthcare professionals with critical insights that improve surgical decision-making and patient outcomes while also aiming to lower healthcare costs.

SupaPass is a versatile platform designed for businesses to create their own websites and mobile applications without requiring technical expertise. Founded in 2011, SupaPass enables clients to launch aesthetically appealing and payment-ready content platforms that cater to a diverse range of sectors, including podcasting, fitness, music, and charities. Its innovative white-label technology allows clients to retain full ownership of their customer data and 100% of sales revenue. By offering an intuitive and cost-effective solution, SupaPass makes it significantly faster and cheaper for content creators to manage their offerings, including podcasts, videos, and streaming channels. The platform features a user-friendly layout reminiscent of popular streaming services, empowering clients to maintain their own branding while effectively engaging with their audiences.

10to8 Limited is a company that specializes in developing appointment scheduling software solutions. Founded in September 2011 by Matthew Cleevely, Bruce Johnson, Tom Playford, and Nigel Playford, the company is headquartered in Cambridge, United Kingdom. 10to8 serves a diverse range of sectors, including enterprise, healthcare, beauty and salons, sports and fitness, as well as professional services, tradesmen, tutors, and therapists, providing a platform that allows users to book appointments and manage team availability effectively.

PneumaCare Limited is a UK-based company founded in 2008 that specializes in developing non-invasive systems for assessing and monitoring lung function. The company’s flagship product, PneumaScan, utilizes structured light plethysmography technology to evaluate lung function without requiring patient interaction with the device. This innovative approach allows for natural breathing assessments, minimizing discomfort and the risk of infection. PneumaCare's product lineup includes Thora-3Di™, Thora-3Di Infant, Thora-3Di Compact, PneumaView 3D, and Thora3Di Remote, all designed to cater to a diverse range of patients, including infants, elderly individuals, and those in intensive care. By employing advanced 3D imaging technology developed in collaboration with the University of Cambridge, PneumaCare enables clinicians to obtain accurate pulmonary function outputs while enhancing patient comfort and reducing operational costs associated with traditional spirometry methods. The company's systems are currently being evaluated in clinical practices at notable hospitals, showcasing their potential to transform respiratory monitoring in various medical environments.

Anvil Semiconductors Ltd is a company specializing in the development of silicon carbide (SiC) materials and devices tailored for the power electronics and LED markets. Established in 2010 as a spin-out from the University of Warwick, Anvil focuses on creating vertical Schottky barrier diodes and MOSFETs using its proprietary 3C-SiC on silicon wafers. The company’s technology aims to deliver SiC-based devices at costs comparable to existing silicon-based solutions while enhancing performance, particularly in operating efficiency. Anvil's products find applications across various sectors, including photovoltaics, consumer electronics, uninterruptible power supplies, electric vehicles, and LED lighting. With its headquarters in Coventry and an additional office in Cambridge, Anvil Semiconductors is positioned to address the growing demand for advanced power electronics, which is projected to expand significantly in the coming years.

Eagle Genomics is an enterprise software solutions company specializing in the management and analysis of genomics and life sciences data. Its innovative platform facilitates the curation, integration, sharing, and analysis of scientific data, thereby enhancing productivity and reducing costs and time in research and development. By transforming data sets into valuable assets, the company redefines how digital information is measured and utilized, providing insights into the return on information. With a unique blend of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics addresses the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech, particularly in managing the increasing volume of data. The company is positioned at the forefront of delivering the essential information architecture needed for the genomics era, helping clients navigate the complexities of data-driven research and development.

SwiftKey is a technology company based in London, UK, founded in 2008 by Ben Medlock and Jon Reynolds. The company specializes in developing a smart and customizable keyboard application that utilizes artificial intelligence to enhance typing efficiency on mobile devices. By learning from user behavior, SwiftKey's software provides advanced auto-correction and next-word prediction features, which significantly improve typing speed and accuracy. The SwiftKey Keyboard supports over 80 languages, making it a versatile tool for a diverse range of users. Its focus on personalizing the typing experience allows for more contextually aware and relevant suggestions, reflecting individual writing styles.

Cambridge Communication Systems Limited, founded in 2010 and based in Cambridge, United Kingdom, specializes in designing and developing advanced wireless backhaul solutions. The company focuses on self-organizing technologies that provide connectivity for various applications, including small cell networks, Wi-Fi, CCTV, smart cities, and enterprise access. Its flagship product, Metnet, is a self-organizing 5G microwave backhaul system that operates in the 24/26/28GHz frequency range. Cambridge Communication Systems aims to deliver gigabit connectivity through intelligent, self-optimizing, and self-healing mesh networks, which serve as a cost-effective extension of fiber infrastructure. This innovative approach allows network operators to create hybrid fiber-wireless networks, optimizing total cost of ownership across diverse environments, from urban to rural areas and residential to enterprise settings.

Featurespace is a leading company specializing in enterprise financial crime prevention, focusing on fraud and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are integrated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries, allowing financial institutions to detect suspicious activities and mitigate fraud in real-time. The ARIC Risk Hub employs advanced anomaly detection techniques to help organizations identify and respond to emerging fraud threats while ensuring legitimate customer transactions are not hindered. With over 30 major global financial institutions utilizing its platform, Featurespace aims to enhance fraud management, improve customer satisfaction, and drive revenue growth for its clients.

Cambridge Communication Systems Limited, founded in 2010 and based in Cambridge, United Kingdom, specializes in designing and developing advanced wireless backhaul solutions. The company focuses on self-organizing technologies that provide connectivity for various applications, including small cell networks, Wi-Fi, CCTV, smart cities, and enterprise access. Its flagship product, Metnet, is a self-organizing 5G microwave backhaul system that operates in the 24/26/28GHz frequency range. Cambridge Communication Systems aims to deliver gigabit connectivity through intelligent, self-optimizing, and self-healing mesh networks, which serve as a cost-effective extension of fiber infrastructure. This innovative approach allows network operators to create hybrid fiber-wireless networks, optimizing total cost of ownership across diverse environments, from urban to rural areas and residential to enterprise settings.

SwiftKey is a technology company based in London, UK, founded in 2008 by Ben Medlock and Jon Reynolds. The company specializes in developing a smart and customizable keyboard application that utilizes artificial intelligence to enhance typing efficiency on mobile devices. By learning from user behavior, SwiftKey's software provides advanced auto-correction and next-word prediction features, which significantly improve typing speed and accuracy. The SwiftKey Keyboard supports over 80 languages, making it a versatile tool for a diverse range of users. Its focus on personalizing the typing experience allows for more contextually aware and relevant suggestions, reflecting individual writing styles.

Arachnys Information Services Limited, founded in 2010 and based in Cambridge, United Kingdom, specializes in developing cloud-based solutions that enhance the assessment of financial crime risks and compliance with customer due diligence, know your customer, and enhanced due diligence regulations. The company offers a web crawler and deep-web search engine that enables access to hard-to-reach information, particularly from emerging markets such as India, China, Russia, and the Middle East. Arachnys addresses the challenges posed by fragmented and disorganized data in these regions by employing advanced spidering and scraping technology, which allows businesses to extract valuable insights from siloed corporate and governmental datasets. Its services cater to investment banks, hedge funds, law firms, accountants, and risk consultancies seeking growth opportunities in complex markets while minimizing associated risks.

PneumaCare Limited is a UK-based company founded in 2008 that specializes in developing non-invasive systems for assessing and monitoring lung function. The company’s flagship product, PneumaScan, utilizes structured light plethysmography technology to evaluate lung function without requiring patient interaction with the device. This innovative approach allows for natural breathing assessments, minimizing discomfort and the risk of infection. PneumaCare's product lineup includes Thora-3Di™, Thora-3Di Infant, Thora-3Di Compact, PneumaView 3D, and Thora3Di Remote, all designed to cater to a diverse range of patients, including infants, elderly individuals, and those in intensive care. By employing advanced 3D imaging technology developed in collaboration with the University of Cambridge, PneumaCare enables clinicians to obtain accurate pulmonary function outputs while enhancing patient comfort and reducing operational costs associated with traditional spirometry methods. The company's systems are currently being evaluated in clinical practices at notable hospitals, showcasing their potential to transform respiratory monitoring in various medical environments.

Oval Medical Technologies Limited is a specialty pharmaceutical device company based in Cambridge, United Kingdom, founded in 2009. The company specializes in designing and developing innovative drug delivery devices, including vials, prefilled syringes, and autoinjectors. Its technology enables patients across various age groups and therapeutic areas to self-inject both viscous and non-viscous medications. Oval Medical Technologies serves the pharmaceutical and biotechnology industries, focusing on enhancing medical safety through its advanced autoinjector solutions. As of December 2016, it operates as a subsidiary of SMC Ltd.

Augmentra Ltd is a company based in Cambridge, United Kingdom, specializing in GPS navigation software through its flagship product, ViewRanger. Founded in 2006, Augmentra develops tools that assist users in planning, navigating, recording, and sharing outdoor activities such as walking, hiking, and biking. The ViewRanger application incorporates augmented reality features, enhancing the outdoor experience for millions of active individuals. As of May 2020, Augmentra operates as a subsidiary of Outdooractive GmbH, further expanding its reach in the outdoor adventure industry.

Enval Limited is a recycling technology company based in Huntingdon, United Kingdom, founded in 2005 as a spin-out from the University of Cambridge's Department of Chemical Engineering. The company specializes in designing and manufacturing recycling equipment and modular plants that utilize microwave-induced pyrolysis to recycle complex plastic-aluminium laminates, such as those found in drink cartons and toothpaste tubes. Enval aims to provide sustainable and economically viable alternatives to landfills by extracting commercially usable aluminum, oil, and gas from these materials. In addition to its technological innovations, Enval offers environmental life cycle analysis and technology consultancy services, focusing on the pyrolytic recycling of flexible packaging materials. The company serves a diverse clientele, including waste handlers, local authorities, fast-moving consumer goods brands, and consumers, addressing environmental and regulatory challenges across various sectors.

Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, that specializes in developing innovative antibiotics to combat antibacterial resistance. The company utilizes its proprietary SASPject platform, which employs small acid-soluble spore proteins delivered via targetable non-delivery vehicles to specific bacterial strains. Its product portfolio includes SASPject PT3, designed to target Pseudomonas aeruginosa; SASPject PT4 and PT5, which are aimed at Klebsiella pneumonia and Escherichia coli, respectively; and SASPject PT1.2, focused on Staphylococcus aureus. Additionally, Phico Therapeutics is working on an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses in conjunction with antibacterial proteins to inhibit bacterial growth and toxin release. Founded in 2000, the company is dedicated to addressing critical challenges in antibiotic resistance through its advanced therapeutic approaches.

Nujira is a company specializing in power amplifier technology for the wireless communications industry. They develop High Accuracy Tracking (HAT) Power Modulators designed to enhance the efficiency and flexibility of base stations, transmitters, and cellular terminals. Their technology supports various standards including 3G, evolved 3G, DVB, and WiMAX, enabling equipment vendors to create smaller, more cost-effective solutions that meet the growing demands of operators and broadcasters globally. Nujira holds over 200 patents related to envelope tracking technology, which is crucial for powering energy-efficient fourth-generation cellular devices.

Metalysis Limited is a technology company based in Rotherham, United Kingdom, specializing in the manufacture of high-value metals and alloys, including titanium and tantalum. Established in 2001, the company has developed a solid-state process for producing metal alloy powders, which are primarily utilized in advanced manufacturing, aerospace, and automotive sectors. This innovative process, originally conceived at The University of Cambridge, offers a more environmentally friendly and energy-efficient alternative to conventional melting methods. Metalysis focuses on creating 3D printable metal powders and niche, high-performance alloys, catering to the needs of various industries. The company is advancing its production capabilities through its Generation 4 technological expansion, aiming to scale up its manufacturing processes.

Nujira is a company specializing in power amplifier technology for the wireless communications industry. They develop High Accuracy Tracking (HAT) Power Modulators designed to enhance the efficiency and flexibility of base stations, transmitters, and cellular terminals. Their technology supports various standards including 3G, evolved 3G, DVB, and WiMAX, enabling equipment vendors to create smaller, more cost-effective solutions that meet the growing demands of operators and broadcasters globally. Nujira holds over 200 patents related to envelope tracking technology, which is crucial for powering energy-efficient fourth-generation cellular devices.

Kaptivo is a technology company that develops a whiteboard camera designed to enhance visual collaboration for businesses and educational institutions. Utilizing artificial intelligence, Kaptivo's product enables live-streaming of whiteboard content during remote meetings, incorporating features such as automatic note-taking to streamline the collaboration process. By integrating seamlessly with popular communication platforms like Zoom, Cisco Webex, Microsoft Teams, and Slack, Kaptivo helps organizations improve productivity while ensuring content security. The company's innovative solutions address the growing demand for effective remote collaboration tools in today's digital landscape.

Ubisense is a leading provider of Precise Real-Time Location Systems, specializing in enterprise business automation through advanced tracking of people and assets. The company offers a real-time enterprise location platform designed to assist organizations in their factory digitization efforts. By generating and interpreting extensive location data, Ubisense creates visibility into real-world objects and their interactions, enabling clients to make informed decisions with greater flexibility and adaptability. The company's innovative solutions address complex business challenges, allowing for enhanced operational efficiency and control.

Camrivox Ltd is a company based in Cambridge, UK, that specializes in telephony integration with customer relationship management (CRM) systems. Founded in 2005, Camrivox has developed Flexor Software, which simplifies the traditionally complex and resource-intensive process of CRM telephony integration. By providing a solution that operates at the PC level, Camrivox enables businesses to enhance their communication capabilities without the need for significant investments in infrastructure and support staff. The company also manufactures voice-over internet protocol equipment tailored for home users and small businesses, facilitating the integration of telephony, instant messaging, and presence management with CRM services. This focus on accessible and effective communication solutions aims to improve business processes and elevate customer satisfaction.

Nujira is a company specializing in power amplifier technology for the wireless communications industry. They develop High Accuracy Tracking (HAT) Power Modulators designed to enhance the efficiency and flexibility of base stations, transmitters, and cellular terminals. Their technology supports various standards including 3G, evolved 3G, DVB, and WiMAX, enabling equipment vendors to create smaller, more cost-effective solutions that meet the growing demands of operators and broadcasters globally. Nujira holds over 200 patents related to envelope tracking technology, which is crucial for powering energy-efficient fourth-generation cellular devices.

Metalysis Limited is a technology company based in Rotherham, United Kingdom, specializing in the manufacture of high-value metals and alloys, including titanium and tantalum. Established in 2001, the company has developed a solid-state process for producing metal alloy powders, which are primarily utilized in advanced manufacturing, aerospace, and automotive sectors. This innovative process, originally conceived at The University of Cambridge, offers a more environmentally friendly and energy-efficient alternative to conventional melting methods. Metalysis focuses on creating 3D printable metal powders and niche, high-performance alloys, catering to the needs of various industries. The company is advancing its production capabilities through its Generation 4 technological expansion, aiming to scale up its manufacturing processes.

Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, that specializes in developing innovative antibiotics to combat antibacterial resistance. The company utilizes its proprietary SASPject platform, which employs small acid-soluble spore proteins delivered via targetable non-delivery vehicles to specific bacterial strains. Its product portfolio includes SASPject PT3, designed to target Pseudomonas aeruginosa; SASPject PT4 and PT5, which are aimed at Klebsiella pneumonia and Escherichia coli, respectively; and SASPject PT1.2, focused on Staphylococcus aureus. Additionally, Phico Therapeutics is working on an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses in conjunction with antibacterial proteins to inhibit bacterial growth and toxin release. Founded in 2000, the company is dedicated to addressing critical challenges in antibiotic resistance through its advanced therapeutic approaches.

Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, that specializes in developing innovative antibiotics to combat antibacterial resistance. The company utilizes its proprietary SASPject platform, which employs small acid-soluble spore proteins delivered via targetable non-delivery vehicles to specific bacterial strains. Its product portfolio includes SASPject PT3, designed to target Pseudomonas aeruginosa; SASPject PT4 and PT5, which are aimed at Klebsiella pneumonia and Escherichia coli, respectively; and SASPject PT1.2, focused on Staphylococcus aureus. Additionally, Phico Therapeutics is working on an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses in conjunction with antibacterial proteins to inhibit bacterial growth and toxin release. Founded in 2000, the company is dedicated to addressing critical challenges in antibiotic resistance through its advanced therapeutic approaches.